iShares Morningstar Mid-Cap Growth ETF (JKH)
280.39
-4.32 -1.52%
NYSE Arca
Feb 21, 20:00
Delayed 2m
USD
Key Stats
| Expense Ratio | 0.30% |
| Total Assets Under Management | 560.72M |
| Share Class Assets Under Management | 560.72M |
| 30-Day Average Daily Volume | 12611.57 |
| Net Asset Value | 280.36 |
| Discount or Premium to NAV | 0.01% |
| Turnover Ratio | 30.00% |
| 1 Year Fund Level Flows | 125.59M |
Performance & Returns
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 1.86% | 1.88% | 1.77% | 40 |
| 3M | 10.48% | 10.44% | 9.67% | 32 |
| 6M | 12.49% | 12.47% | 12.24% | 39 |
| YTD | 6.62% | 6.58% | 5.83% | 36 |
| 1Y | 24.35% | 24.46% | 21.14% | 32 |
| 3Y | 17.63% | 17.62% | 15.09% | 26 |
| 5Y | 11.71% | 11.70% | 10.65% | 35 |
| 10Y | 14.41% | 14.42% | 13.39% | 33 |
| 15Y | 10.54% | 10.55% | 9.65% | 30 |
| 20Y | -- | -- | 7.02% | -- |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.08% | 0.08% | 0.00% |
| Stock | 99.92% | 99.92% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
Region Exposure
| Americas | 100.0% |
| North America | 98.52% |
| Latin America | 1.48% |
| Greater Europe | 0.00% |
| United Kingdom | 0.00% |
| Europe Developed | 0.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.00% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 98.52% |
| % Emerging Markets | 1.48% |
Stock Sector Exposure
| Basic Materials | 1.99% |
| Communication Services | 6.45% |
| Consumer Cyclical | 11.38% |
| Consumer Defensive | 1.72% |
| Energy | 2.71% |
| Financial Services | 4.90% |
| Healthcare | 21.48% |
| Industrials | 12.90% |
| Real Estate | 3.29% |
| Technology | 33.18% |
| Utilities | 0.00% |
Stock Market Capitalization
| Giant | 0.00% |
| Large | 31.95% |
| Medium | 67.89% |
| Small | 0.16% |
| Micro | 0.00% |
Stock Style Exposure
| Large Cap Value | 0.00% |
| Large Cap Blend | 5.22% |
| Large Cap Growth | 26.94% |
| Mid Cap Value | 0.38% |
| Mid Cap Blend | 6.80% |
| Mid Cap Growth | 60.49% |
| Small Cap Value | 0.00% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.16% |
View More Holdings
As of Feb. 20, 2020
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| MELI | MercadoLibre Inc | 1.48% | 735.60 | -0.94% |
| SBAC | SBA Communications Corp | 1.45% | 295.65 | +1.20% |
| INFO | IHS Markit Ltd | 1.42% | 79.06 | -1.72% |
| LULU | Lululemon Athletica Inc | 1.39% | 255.90 | -2.95% |
| TWTR | Twitter Inc | 1.34% | 38.31 | -1.90% |
| SQ | Square Inc A | 1.29% | 83.49 | -2.58% |
| VRSK | Verisk Analytics Inc | 1.22% | 168.69 | -0.41% |
| DXCM | DexCom Inc | 1.22% | 291.25 | -3.72% |
| FLT | Fleetcor Technologies Inc | 1.21% | 308.92 | -2.67% |
| MSCI | MSCI Inc | 1.20% | 309.08 | -3.93% |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks to track the investment results of the Morningstar® US Mid Growth IndexSM composed of mid-capitalization U.S. equities that exhibit growth characteristics. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of stocks issued by mid-capitalization companies that have exhibited above-average "growth" characteristics as determined by Morningstar, Inc.'s ("Morningstar" or the "index provider") proprietary index methodology. | |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Growth |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
| Morningstar US Mid Growth TR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 3.71 yrs |
| Amy Whitelaw | 1.33 yrs |
| Greg Savage | 12.01 yrs |
| Jennifer Hsui | 7.33 yrs |
| Rachel Aguirre | 1.33 yrs |
Net Fund Flows
| 1M | 0.00 |
| 3M | -98.61M |
| 6M | -85.84M |
| YTD | 0.00 |
| 1Y | 125.59M |
| 3Y | 179.95M |
| 5Y | 156.86M |
| 10Y | 92.98M |
Risk Info
| Beta (5Y) | 1.073 |
| Max Drawdown (All) | 58.96% |
| Historical Sharpe Ratio (10Y) | 1.014 |
| Historical Sortino (All) | 0.6052 |
| 30-Day Rolling Volatility | 13.53% |
| Daily Value at Risk (VaR) 1% (All) | 3.64% |
| Monthly Value at Risk (VaR) 1% (All) | 16.91% |
Fundamentals
| Dividend Yield TTM (2-21-20) | 0.42% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 33.40 |
| Weighted Average Price to Sales Ratio | 4.857 |
| Weighted Average Price to Book Ratio | 6.074 |
| Weighted Median ROE | 17.16% |
| Weighted Median ROA | 7.31% |
| Forecasted Dividend Yield | 0.43% |
| Forecasted PE Ratio | 30.95 |
| Forecasted Price to Sales Ratio | 4.264 |
| Forecasted Price to Book Ratio | 5.104 |
| Number of Holdings | 181 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 14.28% |
| Forecasted Book Value Growth | 13.91% |
| Forecasted Cash Flow Growth | 20.19% |
| Forecasted Earnings Growth | 25.08% |
| Forecasted Revenue Growth | 11.49% |
Attributes
| Key Dates | |
|---|---|
| Inception Date | 6/28/2004 |
| Termination Date | |
| Last Annual Report Date | 4/30/2019 |
| Last Prospectus Date | 8/30/2019 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
